Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA 4258, FR CNRS 3038 INC3M, UFR des Sciences Pharmaceutiques, Université de Caen Basse-Normandie, bd Becquerel, 14032 Caen Cedex, France.
J Pharm Sci. 2010 Nov;99(11):4603-15. doi: 10.1002/jps.22177.
Lipidic nanoparticles (NP), formulated from a phase inversion temperature process, have been studied with chemometric techniques to emphasize the influence of the four major components (Solutol®, Labrasol®, Labrafac®, water) on their average diameter and their distribution in size. Typically, these NP present a monodisperse size lower than 200 nm, as determined by dynamic light scattering measurements. From the application of the partial least squares (PLS) regression technique to the experimental data collected during definition of the feasibility zone, it was established that NP present a core-shell structure where Labrasol® is well encapsulated and contributes to the structuring of the NP. Even if this solubility enhancer is regarded as a pure surfactant in the literature, it appears that the oil moieties of this macrogolglyceride mixture significantly influence its properties. Furthermore, results have shown that PLS technique can be also used for predictions of sizes for given relative proportions of components and it was established that from a mixture design, the quantitative mixture composition to use in order to reach a targeted size and a targeted polydispersity index (PDI) can be easily predicted. Hence, statistical models can be a useful tool to control and optimize the characteristics in size of NP.
脂纳米粒(NP)由相转变温度过程形成,已经使用化学计量技术进行了研究,以强调四个主要成分(Solutol®、Labrasol®、Labrafac®、水)对其平均直径及其尺寸分布的影响。通常,这些 NP 的粒径低于 200nm,这是通过动态光散射测量确定的。从偏最小二乘(PLS)回归技术在可行性区域定义过程中收集的实验数据的应用中可以看出,NP 呈现出核壳结构,其中 Labrasol®被很好地包裹,并有助于 NP 的结构形成。即使在文献中,这种增溶剂被认为是一种纯表面活性剂,但这种大分子甘油酯混合物的油部分似乎对其性质有很大影响。此外,结果表明,PLS 技术也可用于预测给定组分相对比例的粒径,并且可以从混合物设计中确定,为了达到目标粒径和目标多分散指数(PDI),可以很容易地预测所需使用的定量混合物组成。因此,统计模型可以成为控制和优化 NP 粒径特性的有用工具。